ChemicalBook > Product Catalog >API >Antipyretic analgesics >Nonsteroidal Anti-Inflammatory Drugs (NSAIDS) >Afasevikumab

Afasevikumab

Request For Quotation
Afasevikumab Suppliers list
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Company Name: Guangzhou Hongyuan Chemical Co.,Ltd  
Tel: 15817493340
Email: 981810490@qq.com
Company Name: Wuhan Chemstan Biotechnology Co., Ltd.  
Tel: 027-65317797 15926423062
Email: 422450190@qq.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: Biolab Reagents  
Tel: 027-65279366 18108604356
Email: products@biolabreagent.com
Afasevikumab Basic information
Product Name:Afasevikumab
Synonyms:Afasevikumab;Research Grade Afasevikumab(DHH28807);Research Grade Afasevikumab
CAS:1589503-30-9
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Afasevikumab Structure
Afasevikumab Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Afasevikumab Usage And Synthesis
UsesAfasevikumab (RG 7624; RO 5553110; NI-1401) is a fully human monoclonal IgG1κ antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities[1].
References[1] Andrea Chiricozzi, et al. Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential. Psoriasis (Auckl). 2019 May 24;9:29-35. DOI:10.2147/PTT.S179283
Afasevikumab Preparation Products And Raw materials
Tag:Afasevikumab(1589503-30-9) Related Product Information
Codrituzumab Mupadolimab Alirocumab Lexatumumab Namilumab Suvizumab Daxdilimab Glembatumumab Pritumumab Utomilumab